Xiaoshun He
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| TCR-Redirected T Cell Treatment in Patients With Recurrent HBV-related Hepatocellular Carcinoma Post Liver Transplantation (NCT04677088) | Xiaoshun He | 2018-03-29 |
Track Xiaoshun He automatically
Every clearance here is in the API, with alerts when new ones post.